U.S. Pain celebrated a cautious victory this month after the defeat of a controversial Medicare Part B proposal that would have incentivized the use of lower-cost drugs. U.S. Pain created and led a campaign, “Patients for Medicare Access,” to fight the change.

“Congressional leaders requested that the Obama administration withdraw the final rule implementing the proposal,” says Paul Gileno, president and founder of U.S. Pain, who published a Dec. 21 op-ed in The Hill about the campaign’s success. “While the rule could still be revived, we are cautiously optimistic that the effort has been successfully blocked.”

Read More